caffeic acid phenethyl ester has been researched along with oxidopamine in 4 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodel, R; Du, Y; Fontanilla, C; Hampel, H; Ma, Z; Noelker, C; Wei, X | 1 |
| Baffa, O; Barbosa, F; Barros Silva, R; Del-Bel, E; Ferreira, DA; Kinoshita, A; Martins, NM; Oliveira Souza, VC; Santos, AC; Santos, NA | 1 |
| Hori, O; Konishi, T; Le, TM; Matsugo, S; Nakamura, Y; Nishiuchi, T; Takakura, K; Takatou, S; Tomiyama, R | 1 |
| Abdik, H; Avşar Abdik, E; Sahin, F; Turan, D | 1 |
4 other study(ies) available for caffeic acid phenethyl ester and oxidopamine
| Article | Year |
|---|---|
Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity.
Topics: Animals; Animals, Newborn; Antioxidants; Caffeic Acids; Cell Death; Cerebellum; Free Radicals; Immunohistochemistry; In Vitro Techniques; Mesencephalon; Neurons; Neurotoxicity Syndromes; Oxidopamine; Peroxynitrous Acid; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Sympatholytics | 2006 |
Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats.
Topics: Adrenergic Agents; Animals; Antioxidants; Caffeic Acids; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Free Radical Scavengers; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phenylethyl Alcohol; Rats; Rats, Wistar | 2013 |
3,4-dihydroxybenzalacetone and caffeic acid phenethyl ester induce preconditioning ER stress and autophagy in SH-SY5Y cells.
Topics: Autophagy; Caffeic Acids; Cell Line, Tumor; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation; Humans; Microtubule-Associated Proteins; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Phenylethyl Alcohol; Signal Transduction; Time Factors; Unfolded Protein Response | 2018 |
Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
Topics: Antiparkinson Agents; Apoptosis; Apoptosis Regulatory Proteins; Caffeic Acids; Cell Line, Tumor; Humans; Membrane Potential, Mitochondrial; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Phenylethyl Alcohol; Reactive Oxygen Species; Signal Transduction | 2020 |